I guess you'd be a good person to start with, because a lot of you have been involved with the anti-nicotine drug trials. I think you were all pretty concerned about what happened after it had been approved.
In terms of post-market surveillance, we found that we don't do a good job on post-market surveillance, and a whole bunch of people died when trying to come off a drug. I just think we should put this study in perspective in regard to where the pharmaceutical industry is and why there has been no research on this drug because there's no pharmaceutical company pushing studies for this kind of evidence.